Key Takeaways
- MDB reached a 52-week peak of $447.00, now trading near $452.89
- The stock has surged 114% year-over-year
- Oppenheimer increased its target from $410 to $475 with an Outperform designation
- Several Wall Street firms including Needham, Tigress Financial, and Stifel have upgraded their forecasts
- GF Value assessment indicates MDB trades approximately 14% above intrinsic value
MongoDB (MDB) stock reached a 52-week peak of $447.00 on August 13, with current trading levels at $452.89. This represents a remarkable 114% appreciation over the trailing twelve months, capturing widespread attention from institutional investors.
The most recent catalyst arrived from Oppenheimer on August 12, elevating its price objective on MDB from $410 to $475 while maintaining an Outperform designation. This reflects a 15.85% increase in the firm’s valuation outlook.
Wall Street sentiment remains broadly positive. Needham established a $430 objective, emphasizing artificial intelligence expenditure as a favorable catalyst for MongoDB’s growth trajectory. Tigress Financial demonstrated even greater conviction with a $515 forecast, highlighting the company’s strategic positioning within AI-driven data infrastructure.
Stifel elevated its projection to $435, attributing this to robust Atlas platform expansion and improving consumption patterns. Cantor Fitzgerald maintained an Overweight stance with a $416 target, underscoring MongoDB’s critical role in AI data architecture.
The first-quarter financial performance fueling this analyst enthusiasm featured Atlas revenue expansion of 29%, surpassing consensus by approximately 3 percentage points. Overall revenue exceeded projections by $23.1 million.
Financial Metrics Analysis
MongoDB’s market capitalization currently stands at roughly $35.2 billion. Trailing twelve-month revenue expansion hovers around 24%. The price-to-sales multiple registers at approximately 16.3x, consistent with its historical median of 16.28x.
However, profitability remains elusive. The company’s trailing twelve-month earnings per share of -$0.37 means conventional price-to-earnings analysis cannot be applied.
According to GF Value methodology, the stock’s intrinsic worth equals $387.49, indicating MDB currently trades roughly 13.7% above that benchmark. The company’s GF Score of 83 out of 100 demonstrates robust growth and momentum characteristics, though profitability scores a weak 3 out of 10.
Trading Activity from Insiders and Institutions
Notably, insider sentiment tells a different story. Company executives and directors have divested $53.7 million in shares during the past quarter, with no insider purchases recorded during this timeframe.
On the institutional front, 10 investment gurus maintain positions in MDB, with 4 increasing their stakes while 7 reduced exposure. The activity presents a divided perspective.
Citigroup, Truist Securities, and Bank of America have each sustained Buy recommendations while raising price objectives. This widespread analyst support maintains constructive sentiment despite the insider liquidation pattern.
The company’s GF Score of 83 highlights solid fundamentals in expansion and price momentum, while simultaneously identifying profitability as a persistent vulnerability.
Oppenheimer’s updated $475 forecast stands as among the latest guidance available, issued on August 12, 2026.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
